PharmaDrug Inc’s Innovative Cocaine Supply Solution

Pharmadrug Inc. (TSE:PHRX) has released an update.

PharmaDrug Inc. has announced a breakthrough in safe drug supply by filing a patent for a biosynthetic method to manufacture pharmaceutical grade cocaine, aiming to support harm reduction programs. The company’s initiative targets the development of a reliable and cost-effective production process that could revolutionize the supply chain for controlled substances. PharmaDrug is moving swiftly to develop this innovative method, which they believe will offer significant benefits to public health and provide a new revenue stream through global partnerships.

For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.